SciTransfer
Organization

DEPARTMENT OF HEALTH

Ireland's national health ministry contributing policy authority and data governance to EU cross-border eHealth and population health infrastructure projects.

Public authorityhealthIEThin data (2/5)
H2020 projects
3
As coordinator
0
Total EC funding
€240K
Unique partners
98
What they do

Their core work

Ireland's Department of Health is the national government body responsible for health policy, regulation, and public health infrastructure. In the H2020 context, it contributes national-level health data governance expertise, particularly around cross-border electronic health records, medicines identification standards, and population health research infrastructure. Their participation reflects Ireland's commitment to EU-wide health data interoperability and public health monitoring, bringing regulatory authority and national health system perspective to digital health consortia.

Core expertise

What they specialise in

Cross-border eHealth and health data interoperabilityprimary
2 projects

Central role in both UNICOM (medicines identification standards) and X-eHealth (electronic health record exchange frameworks).

Medicines identification and pharmacovigilance standardsprimary
1 project

Participated in UNICOM, focused on IDMP standards, drug databases, and EMA-aligned pharmacovigilance.

Population health research infrastructuresecondary
1 project

Contributed to PHIRI, building research infrastructure for COVID-19 population health data and international comparisons.

Electronic health record standards (EHRxF)secondary
1 project

Participated in X-eHealth developing common frameworks for laboratory results, discharge reports, and medical imaging exchange.

Evolution & trajectory

How they've shifted over time

Early focus
Medicines data standardisation
Recent focus
Population health data infrastructure

All three projects fall within 2019–2024, so the evolution window is narrow. Early involvement centered on digital infrastructure for medicines — standardising drug identification (IDMP) and cross-border eHealth networks. By 2020, the focus broadened to health record exchange frameworks and population-level health research, particularly driven by COVID-19 data needs. The shift suggests a move from pharmaceutical data standardisation toward broader public health data infrastructure.

Moving toward large-scale health data sharing and research infrastructure, likely to engage in European Health Data Space (EHDS) initiatives.

Collaboration profile

How they like to work

Role: active_partnerReach: European32 countries collaborated

The Department of Health participates exclusively as a partner, never as coordinator — consistent with a national authority contributing policy expertise and data governance perspective rather than leading technical development. With 98 unique partners across 32 countries from just 3 projects, they operate in very large consortia (30+ partners each), indicating comfort with complex, multi-national governance structures. This makes them a reliable institutional partner who brings national-level authority and regulatory legitimacy to consortia.

Despite only 3 projects, the Department has collaborated with 98 unique partners across 32 countries, reflecting participation in large pan-European health infrastructure consortia. Their network spans nearly all EU/EEA member states, typical of health policy coordination efforts.

Why partner with them

What sets them apart

As a national health ministry, the Department of Health brings something most research partners cannot: regulatory authority and policy-level decision-making power over Ireland's health data systems. For consortium builders, this means having a government partner who can actually implement cross-border eHealth standards at national level, not just study them. This institutional weight is particularly valuable for projects requiring member-state adoption of EU health data frameworks.

Notable projects

Highlights from their portfolio

  • UNICOM
    Largest project by funding (EUR 172,294), running 5 years on global medicines identification — a major EU-wide standardisation effort involving EMA and national authorities.
  • PHIRI
    Directly responded to the COVID-19 pandemic, building population health research infrastructure for real-time international health data comparisons.
Cross-sector capabilities
Digital health and data interoperabilityPublic administration and governancePharmaceutical regulation and safety
Analysis note: Only 3 projects, all from 2019-2024, with modest funding (total EUR 239K). Profile reflects a government body contributing institutional authority rather than technical research capacity. The small project count limits confidence in trend analysis — the apparent evolution may simply reflect the different scopes of three unrelated consortium invitations rather than a deliberate strategic shift.